PLSE earnings date and last-quarter result: last quarter beat, P/E -30.06. Updated 2026-07-23.
Pulse Biosciences (PLSE) Research Hub
Pulse Biosciences (PLSE) trades on NASDAQ, US in the Healthcare (Medical - Instruments & Supplies) sector. As of 2026-10-26, shares last closed at 52.66 USD (-0.68%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -30.06, market cap 2.24B. This hub links to the full technical, earnings and options research available for PLSE.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Instruments & Supplies) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 52.66 USD (-0.68%) |
| 52-week range | 24.36 USD – 58.9 USD |
| Trend regime | Range |
| 14-day RSI | 56.1 (Bullish) |
| Trailing P/E | -30.06 |
| Market cap | 2.24B |
| Dividend yield | 0.00% |
Available research for PLSE
Covered Call on PLSE: how it works, illustrative setup around the real 52.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PLSE: how it works, illustrative setup around the real 52.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PLSE: how it works, illustrative setup around the real 52.66 USD price, max profit/loss, breakeven and when to use it. Educational.
PLSE technical analysis: range, last 52.66 USD, RSI 56.1, 52w range 24.36 USD–58.9 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PLSE in?
Pulse Biosciences (PLSE) is classified under Healthcare (Medical - Instruments & Supplies), listed on NASDAQ, US.
Is PLSE in an uptrend or downtrend?
As of 2026-10-26, PLSE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PLSE's trailing P/E ratio?
PLSE's trailing P/E is -30.06, with a market cap of 2.24B. See the earnings research page for full valuation detail.